Posted by john on August 26th, 2007 — in Ultram News
New Topical Formula Provides Pain Relief Alternative To Prescription and Over-The-Counter Medications LOS ANGELES, Aug. 21 /PRNewswire/ — The statistics on pain are, well, painful. Nine in ten Americans report suffering regularly from various physical aches and pains with chronic, debilitating pain found to affect more than 44 million American households*. There is a glut […]
1 Comment »
Posted by john on August 19th, 2007 — in Ultram News
But despite the advances in pain management over the years, significant cancer pain is still present in more than 70% of patients. “In good centres, pain is well managed,” says Dr. Allan Gordon, director of the Wasser Pain Management Centre at Mount Sinai Hospital in Toronto. “But there is still room for improvement.” Lots, it […]
1 Comment »
Posted by john on August 15th, 2007 — in Ultram News
BASEL, Switzerland: Novartis AG said it has removed its pain relief drug Prexige from the Australian market, which the national drug regulator called for after two patients died and two others had to undergo liver transplants.
Patients in Australia should stop taking the medication immediately, return any remaining tablets to their pharmacist and seek medical advice […]
2 Comments »
Posted by john on August 10th, 2007 — in Ultram News
Today, Bayer Inc., a subsidiary of Bayer AG, and GW Pharmaceuticals announced that Health Canada has approved SATIVEX(R), a cannabis derived pharmaceutical treatment, as adjunctive analgesic treatment in adult patients with advanced cancer who experience moderate to severe pain during the highest tolerated dose of strong opioid therapy for persistent background pain. SATIVEX, the only […]
No Comments »